tradingkey.logo

Universe Pharmaceuticals Inc

UPC

3.385USD

-0.085-2.44%
Horarios del mercado ETCotizaciones retrasadas 15 min
1.91MCap. mercado
--P/E TTM

Universe Pharmaceuticals Inc

3.385

-0.085-2.44%
Más Datos de Universe Pharmaceuticals Inc Compañía
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Información de la empresa
Símbolo de cotizaciónUPC
Nombre de la empresaUniverse Pharmaceuticals Inc
Fecha de salida a bolsaMar 23, 2021
Director ejecutivoMr. Gang Lai
Número de empleados225
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 23
Dirección265 Jingjiu Avenue
CiudadJI'AN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísChina
Código postal343100
Teléfono867968403309
Sitio Webhttp://www.universe-pharmacy.com/
Símbolo de cotizaciónUPC
Fecha de salida a bolsaMar 23, 2021
Director ejecutivoMr. Gang Lai
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Ms. Tina Xiao
Ms. Tina Xiao
IR Contact Officer
IR Contact Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Sales of TCMD products
14.03M
60.92%
Sales of third-party products
9.00M
39.08%
Por regiónUSD
Nombre
Ganancia
Proporción
China (Mainland)
23.02M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Sales of TCMD products
14.03M
60.92%
Sales of third-party products
9.00M
39.08%
Estadísticas de accionistas
Actualizado: jue., 15 de may
Actualizado: jue., 15 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Sununion Holding Group Ltd
0.62%
UBS Financial Services, Inc.
0.05%
Other
99.34%
Accionistas
Accionistas
Proporción
Sununion Holding Group Ltd
0.62%
UBS Financial Services, Inc.
0.05%
Other
99.34%
Tipos de accionistas
Accionistas
Proporción
Corporation
0.62%
Investment Advisor
0.05%
Other
99.34%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
15
3.73K
0.66%
-14.56K
2025Q1
15
3.73K
8.84%
-14.56K
2024Q4
15
702.49K
4.61%
+518.42K
2024Q3
12
183.86K
3.78%
+44.54K
2024Q2
8
139.13K
0.94%
-3.04K
2024Q1
8
138.86K
57.13%
-3.66K
2023Q4
9
139.20K
57.27%
-3.80K
2023Q3
13
139.26K
57.29%
-143.15K
2023Q2
13
139.86K
57.87%
-142.30K
2023Q1
15
139.56K
57.75%
-143.20K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Sununion Holding Group Ltd
3.47K
0.62%
--
--
Apr 29, 2025
UBS Financial Services, Inc.
266.00
0.05%
+266.00
--
Mar 31, 2025
Sabby Management, LLC
--
0%
-8.33K
-100.00%
Mar 31, 2025
Anson Funds Management LP.
--
0%
-5.76K
-100.00%
Mar 31, 2025
Morgan Stanley & Co. LLC
--
0%
-2.00
-100.00%
Mar 31, 2025
MML Investors Services, LLC
--
0%
-390.00
-100.00%
Dec 31, 2024
Quadrature Capital LLP
--
0%
-41.00
-100.00%
Dec 31, 2024
Virtu Americas LLC
--
0%
-28.00
-100.00%
Dec 31, 2024
Geode Capital Management, L.L.C.
--
0%
-2.00
-100.00%
Oct 31, 2024
Two Sigma Investments, LP
--
0%
-151.00
-100.00%
Dec 31, 2024
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Nov 14, 2024
Merger
15<1
Nov 14, 2024
Merger
15<1
Fecha
Tipo
Relación
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Nov 14, 2024
Merger
15<1
Nov 14, 2024
Merger
15<1
Nov 14, 2024
Merger
15<1
Nov 14, 2024
Merger
15<1
Jul 27, 2023
Merger
6<1
Jul 27, 2023
Merger
6<1
Ver más
KeyAI